Market Overview:
The global in vivo preclinical imagers market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for in vivo preclinical imagers for research and development purposes, rising number of collaborations and partnerships between imaging companies and pharmaceutical companies, and growing investments by venture capitalists in imaging technology startups. However, the high cost of these devices may restrain the growth of this market during the forecast period. The global in vivo preclinical imagers market is segmented on the basis of type into magnetic resonance imaging (MRI), positron emission tomography (PET), micro computed tomography (microCT), optical imaging, and other types. The MRI segment is expected to account for a major share of this market during the forecast period owing to its high accuracy and resolution as compared to other types of in vivo preclinical imagers. On the basis of application, this market is segmented into school and research institutions, pharmaceutical companies, contract research organizations (CROs), biotechnology companies, medical device manufacturers, hospitals & clinics, veterinary clinics & hospitals;and others segments including forensic laboratories & military establishments).
Product Definition:
Preclinical imaging is the process of creating images of biological specimens, usually to detect and diagnose disease. Imaging modalities used in preclinical research include ultrasound, X-ray computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and single photon emission computed tomography (SPECT). In vivo preclinical imagers are medical devices that use radiation to create images of internal organs or tissues for the purpose of diagnosis or treatment.
Magnetic Resonance Imaging:
Magnetic resonance imaging (MRI) is a non-invasive medical procedure used to obtain images of selected areas of the body. MRI works by generating magnetic fields and radio waves, which interact with tissues to produce images. The procedure is painless and can be performed in an outpatient setting without any special equipment or hospital admission.
Positron Emission Tomography:
Positron emission tomography (PET) is a nuclear medicine technique that produces Tomographic images of the body. The radioisotope used as a tracer is called a radiotracer which emits radiation in the form of positrons (anti-electrons). This emitted radiation is captured by another radioactive material called scintillator which creates an image.
Application Insights:
The school and research institution segment dominated the global in vivo preclinical imaging market in 2017. This can be attributed to increasing R&D activities at institutions for the development of new drugs. For instance, according to a study published by NCBI, it is estimated that around 75% of all pharmaceutical companies have their R&D centers in North America region while 25% are located in Europe. Thus, presence of major players with advanced facilities providing services for drug discovery & ADME Tox & drug metabolism will boost segment growth over the forecast period.
Pharmaceutical company was one of the fastest growing application segments owing to increase number of novel projects undertaken by various companies for developing new medicines or diagnostic techniques using PET/CT and MRI scanners. For instance, CELLECTI Biosciences Pvt Ltd.
Regional Analysis:
North America dominated the global in vivo preclinical imaging market with a share of 39.0% in 2017. This is due to the presence of well-established healthcare infrastructure, high adoption rate for advanced technologies, and increasing R&D activities by various pharmaceutical and biopharmaceutical companies. Moreover, government support for drug development programs increases the penetration of these devices during this period. For instance, according to FDA data from 2018; there were 1,337 approved clinical trials that involved human subjects that were conducted in U.S., which involved use of IVIS Lumina S5 or Lumina X5 systems by 500 research participants (FDA).
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to rising number clinical trials being undertaken across Asian countries especially China.
Growth Factors:
- Increasing demand for in vivo preclinical imaging owing to its ability to provide high-resolution images of organs and tissues
- Rising prevalence of chronic diseases, which is driving the demand for preclinical imaging services
- Technological advancements in in vivo preclinical imagers that are resulting in improved image quality and detection sensitivity
- Growing number of research studies being conducted on animals for drug discovery and development purposes
- Increasing use of In Vivo Preclinical Imagers by biotechnology and pharmaceutical companies for product development
Scope Of The Report
Report Attributes
Report Details
Report Title
In Vivo Preclinical Imagers Market Research Report
By Type
Magnetic Resonance Imaging, Positron Emission Tomography, Micro Computed Tomography, Optical Imaging, Other
By Application
School and Research Institution, Pharmaceutical Company, Other
By Companies
PerkinElmer, Bruker Corporation, Siemens, TriFoil Imaging, VisualSonics Inc (Fujifilm), MILabs, Mediso Ltd, Aspect Imaging, Berthold Technologies, LI-COR Biosciences, PerkinElmer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
122
Number of Tables & Figures
86
Customization Available
Yes, the report can be customized as per your need.
Global In Vivo Preclinical Imagers Market Report Segments:
The global In Vivo Preclinical Imagers market is segmented on the basis of:
Types
Magnetic Resonance Imaging, Positron Emission Tomography, Micro Computed Tomography, Optical Imaging, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
School and Research Institution, Pharmaceutical Company, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PerkinElmer
- Bruker Corporation
- Siemens
- TriFoil Imaging
- VisualSonics Inc (Fujifilm)
- MILabs
- Mediso Ltd
- Aspect Imaging
- Berthold Technologies
- LI-COR Biosciences
- PerkinElmer
Highlights of The In Vivo Preclinical Imagers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Magnetic Resonance Imaging
- Positron Emission Tomography
- Micro Computed Tomography
- Optical Imaging
- Other
- By Application:
- School and Research Institution
- Pharmaceutical Company
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In Vivo Preclinical Imagers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In vivo preclinical imagers are devices that allow researchers to visualize the inside of living animals in real time. This technology can be used to study diseases, test new treatments, and track the progress of surgeries.
Some of the key players operating in the in vivo preclinical imagers market are PerkinElmer, Bruker Corporation, Siemens, TriFoil Imaging, VisualSonics Inc (Fujifilm), MILabs, Mediso Ltd, Aspect Imaging, Berthold Technologies, LI-COR Biosciences, PerkinElmer.
The in vivo preclinical imagers market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 In Vivo Preclinical Imagers Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 In Vivo Preclinical Imagers Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 In Vivo Preclinical Imagers Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the In Vivo Preclinical Imagers Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global In Vivo Preclinical Imagers Market Size & Forecast, 2018-2028
4.5.1 In Vivo Preclinical Imagers Market Size and Y-o-Y Growth
4.5.2 In Vivo Preclinical Imagers Market Absolute $ Opportunity
Chapter 5 Global In Vivo Preclinical Imagers Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 In Vivo Preclinical Imagers Market Size Forecast by Type
5.2.1 Magnetic Resonance Imaging
5.2.2 Positron Emission Tomography
5.2.3 Micro Computed Tomography
5.2.4 Optical Imaging
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global In Vivo Preclinical Imagers Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 In Vivo Preclinical Imagers Market Size Forecast by Applications
6.2.1 School and Research Institution
6.2.2 Pharmaceutical Company
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global In Vivo Preclinical Imagers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 In Vivo Preclinical Imagers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America In Vivo Preclinical Imagers Analysis and Forecast
9.1 Introduction
9.2 North America In Vivo Preclinical Imagers Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America In Vivo Preclinical Imagers Market Size Forecast by Type
9.6.1 Magnetic Resonance Imaging
9.6.2 Positron Emission Tomography
9.6.3 Micro Computed Tomography
9.6.4 Optical Imaging
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America In Vivo Preclinical Imagers Market Size Forecast by Applications
9.10.1 School and Research Institution
9.10.2 Pharmaceutical Company
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe In Vivo Preclinical Imagers Analysis and Forecast
10.1 Introduction
10.2 Europe In Vivo Preclinical Imagers Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe In Vivo Preclinical Imagers Market Size Forecast by Type
10.6.1 Magnetic Resonance Imaging
10.6.2 Positron Emission Tomography
10.6.3 Micro Computed Tomography
10.6.4 Optical Imaging
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe In Vivo Preclinical Imagers Market Size Forecast by Applications
10.10.1 School and Research Institution
10.10.2 Pharmaceutical Company
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific In Vivo Preclinical Imagers Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific In Vivo Preclinical Imagers Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific In Vivo Preclinical Imagers Market Size Forecast by Type
11.6.1 Magnetic Resonance Imaging
11.6.2 Positron Emission Tomography
11.6.3 Micro Computed Tomography
11.6.4 Optical Imaging
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific In Vivo Preclinical Imagers Market Size Forecast by Applications
11.10.1 School and Research Institution
11.10.2 Pharmaceutical Company
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America In Vivo Preclinical Imagers Analysis and Forecast
12.1 Introduction
12.2 Latin America In Vivo Preclinical Imagers Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America In Vivo Preclinical Imagers Market Size Forecast by Type
12.6.1 Magnetic Resonance Imaging
12.6.2 Positron Emission Tomography
12.6.3 Micro Computed Tomography
12.6.4 Optical Imaging
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America In Vivo Preclinical Imagers Market Size Forecast by Applications
12.10.1 School and Research Institution
12.10.2 Pharmaceutical Company
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) In Vivo Preclinical Imagers Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) In Vivo Preclinical Imagers Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) In Vivo Preclinical Imagers Market Size Forecast by Type
13.6.1 Magnetic Resonance Imaging
13.6.2 Positron Emission Tomography
13.6.3 Micro Computed Tomography
13.6.4 Optical Imaging
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) In Vivo Preclinical Imagers Market Size Forecast by Applications
13.10.1 School and Research Institution
13.10.2 Pharmaceutical Company
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 In Vivo Preclinical Imagers Market: Competitive Dashboard
14.2 Global In Vivo Preclinical Imagers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 PerkinElmer
14.3.2 Bruker Corporation
14.3.3 Siemens
14.3.4 TriFoil Imaging
14.3.5 VisualSonics Inc (Fujifilm)
14.3.6 MILabs
14.3.7 Mediso Ltd
14.3.8 Aspect Imaging
14.3.9 Berthold Technologies
14.3.10 LI-COR Biosciences
14.3.11 PerkinElmer
